Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity
Author:
Affiliation:
1. Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2784516/jama_rayner_2021_le_210083_1631920971.468.pdf
Reference5 articles.
1. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial.;Wadden;JAMA,2021
2. Gut feelings about diabetes and GLP-1 receptor agonists: lessons to be learnt from studies in functional gastrointestinal disorders.;Rayner;Diabetes Obes Metab,2017
3. GLP-1 RA treatment patterns among type 2 diabetes patients in five European countries.;Divino;Diabetes Ther,2017
4. Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.;Lean;Int J Obes (Lond),2014
5. Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management.;Du;Diabetes Care,2018
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice;Diabetes, Metabolic Syndrome and Obesity;2024-03
2. Gastrointestinal Neuropathy;Contemporary Diabetes;2023
3. Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice;Journal of Inflammation Research;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3